Complete

Disrupting a cellular communication network

Cancer types:

General cancer research

Project period:

Research institute:

Universita degli Studi di Milano

Award amount:

£181,616

Location:

Italy

Researcher Dr Thomas Vaccari

Dr Thomas Vaccari aims to identify weaknesses in a specific cellular communication network, called Notch signalling, which is implicated in a variety of cancers. 

Meet the scientist

Thomas Vaccari is a professor at the University of Milan and enthusiastic runner. His lab studies how cells communicate with each other and how this communication can go wrong. 

The science

His team are using fruit flies to understand more about how this communication network functions. The gene Notch was discovered in the fruit fly but it turned out that the role it plays in normal development, growth, and even in the generation of tumours, is similar to the role it plays in humans. Dr Vaccari hopes that their research will reveal more information about the biological processes that Notch controls, which will ultimately lead to a better understanding of its role in cancer. 

Related projects

Active Spain

Lung cancer

How do cancer cells modify white blood cells to help tumours grow?

Researchers want to help immunotherapy work for more cancer patients by understanding how cancers hijack our immune system and preventing this happening 

Researcher: Dr Andrés Hidalgo

Understanding how cancer cells modify white blood cells to help tumours grow

Active United Kingdom

General cancer research

Can we stop cancer becoming resistant to chemotherapy?

Chemotherapy can sometimes stop working, so this project is hoping to better understand why and find ways to give more, better options to cancer patients.

Researcher: Dr Andrew Beekman

Stopping cancer becoming resistant to chemotherapy

Active United Kingdom

General cancer research

Can we predict which patients will respond to immunotherapy?

This project hopes to open up exciting possibilities for personalised cancer treatment by finding how to predict which patients will respond best to treatment.

Researcher: Professor Tim Elliott

Finding ways to predict which patients will respond to immunotherapy
Share this page